|$25M||07 Dec 2022||Bedford, Massachusetts, United States|
|$27M||20 Sep 2022||London, England, United Kingdom|
|$50M||26 Jul 2022||San Francisco, California, United States|
|$5M||01 Jul 2022||London, England, United Kingdom|
|$6M||04 Mar 2022||London, England, United Kingdom|
|$77M||16 Nov 2021||California, United States|
|$2M||15 Oct 2021||Reading, England, United Kingdom|
|$1M||23 Aug 2021||London, England, United Kingdom|
|$2M||07 Aug 2021||Bath, England, United Kingdom|
– Vori Health announced additional Series A funding from Intermountain Healthcare, Ascension Ventures, and Echo Health Ventures, bringing the total round size to over $50M.
– The round was led by NEA with participation from current investors AlleyCorp and Max Ventures.
– With these strategic partners, Vori Health will continue to expand its full-stack medical offering across the U.S. and will always welcome forward-thinking partners to join forces on this journey to transform care delivery across the nation and beyond.
– Dating app Thursday raised £2.5m (~$3.5M) seed funding.
– The round was led by Ascension Ventures, Best Nights VC (previously M-Venture) the investment arm of Jägermeister, Connect Ventures, and others.
– The company says that 110,000 likes were sent, resulting in 7,500 matches in a single day.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.